- Home
- DYN vs UDMY Comparison
DYN vs UDMY Comparison
Compare DYN & UDMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DYN
- UDMY
- Stock Information
- Founded
- DYN 1984
- UDMY 2009
- Country
- DYN United States
- UDMY United States
- Employees
- DYN N/A
- UDMY N/A
- Industry
- DYN Medicinal Chemicals and Botanical Products
- UDMY Other Consumer Services
- Sector
- DYN Health Care
- UDMY Real Estate
- Exchange
- DYN Nasdaq
- UDMY Nasdaq
- Market Cap
- DYN 848.8M
- UDMY 904.2M
- IPO Year
- DYN 2020
- UDMY 2021
- Fundamental
- Price
- DYN $10.78
- UDMY $6.64
- Analyst Decision
- DYN Strong Buy
- UDMY Buy
- Analyst Count
- DYN 12
- UDMY 10
- Target Price
- DYN $47.73
- UDMY $10.56
- AVG Volume (30 Days)
- DYN 2.8M
- UDMY 1.3M
- Earning Date
- DYN 05-05-2025
- UDMY 04-30-2025
- Dividend Yield
- DYN N/A
- UDMY N/A
- EPS Growth
- DYN N/A
- UDMY N/A
- EPS
- DYN N/A
- UDMY N/A
- Revenue
- DYN N/A
- UDMY $786,565,000.00
- Revenue This Year
- DYN N/A
- UDMY $3.10
- Revenue Next Year
- DYN N/A
- UDMY $5.61
- P/E Ratio
- DYN N/A
- UDMY N/A
- Revenue Growth
- DYN N/A
- UDMY 7.91
- 52 Week Low
- DYN $6.36
- UDMY $5.68
- 52 Week High
- DYN $47.45
- UDMY $11.60
- Technical
- Relative Strength Index (RSI)
- DYN 57.30
- UDMY 43.70
- Support Level
- DYN $7.38
- UDMY $5.87
- Resistance Level
- DYN $8.01
- UDMY $6.94
- Average True Range (ATR)
- DYN 0.91
- UDMY 0.45
- MACD
- DYN 0.44
- UDMY 0.04
- Stochastic Oscillator
- DYN 92.47
- UDMY 50.00
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
About UDMY Udemy Inc.
Udemy Inc operates a marketplace platform at the center of a vibrant knowledge network. The company operates under two operating and reportable segments Consumer and Enterprise, out of which the Enterprise segment derives the maximum revenue. Geographically, the company derives maximum revenue from North America. The company leverages data, technology, and insights for effective learning experiences. It helps individuals and organizations to possess effective skill acquisition and development with flexibility.